Health authorities ordered the Japanese unit of Novartis to shut down most operations for 15 days in March, saying the drug maker failed to report side effects from its products in a timely fashion.
from WSJ.com: US Business http://ift.tt/1avnLcO
via IFTTT
from WSJ.com: US Business http://ift.tt/1avnLcO
via IFTTT
No comments:
Post a Comment